2026 Bruce A. Sullenger: Molecular Biology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Molecular Biology	72	1314	1171	672	586	237	19713

Bruce A. Sullenger publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Bruce A. Sullenger sits on this spectrum.

47 publications 564+

This scientist: 237 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Bruce A. Sullenger D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce A. Sullenger sits on this spectrum.

40 D-Index 145+

This scientist: 72 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

2018 - Fellow, National Academy of Inventors
2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Bruce A. Sullenger is affiliated with Duke University in the United States. Their research encompasses a wide range of topics primarily within Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to several subfields including Molecular Biology, Immunology, Infectious Diseases, Hematology, and Pulmonary and Respiratory Medicine.

The scientist's recent published papers include the following:

Design of therapeutic biomaterials to control inflammation, 2022, Nature Reviews Materials
Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist, 2020, Journal of NeuroInterventional Surgery
DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists, 2022, Biomaterials
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test, 2021, Science Advances
PEG-Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response, 2022, Advanced Materials

Their frequent co-authors include:

Lyra B. Olson
Ibtehaj A. Naqvi
Haixiang Yu
Bryan Kraft
Smita K. Nair

Bruce A. Sullenger has consistently published in several key venues, with multiple publications in the following journals:

Molecular Therapy - Nucleic Acids
Nucleic Acid Therapeutics
Stroke
UNC Libraries
Science Advances

The main topics covered in their work include:

Advanced biosensing and bioanalysis techniques
RNA Interference and Gene Delivery
Blood Coagulation and Thrombosis Mechanisms
COVID-19 Clinical Research Studies
Immune cells in cancer
CRISPR and Genetic Engineering
Heparin-Induced Thrombocytopenia and Thrombosis

Awards received by this scientist include:

Fellow, National Academy of Inventors, 2018
Fellow of the American Association for the Advancement of Science (AAAS), 2014

Best Publications

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

James O McNamara;Eran R Andrechek;Yong Wang;Kristi D Viles

1283
Citations
Aptamers: An Emerging Class of Therapeutics

Shahid M Nimjee;Christopher P Rusconi;Bruce A Sullenger

1162
Citations
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

Bruce A. Sullenger;Humilidad F. Gallardo;Grace E. Ungers;Eli Gilboa

753
Citations
In vivo activity of nuclease-resistant siRNAs.

Juliana M. Layzer;Anton P. Mccaffrey;Alice K. Tanner;Zan Huang

752
Citations
Notch promotes radioresistance of glioma stem cells

Jialiang Wang;Timothy P. Wakeman;Justin D. Lathia;Anita B. Hjelmeland

750
Citations
RNA aptamers as reversible antagonists of coagulation factor IXa.

Christopher P. Rusconi;Elizabeth Scardino;Juliana Layzer;George A. Pitoc

657
Citations
Emerging clinical applications of RNA

Bruce A. Sullenger;Eli Gilboa

572
Citations
Aptamers as Therapeutics

Shahid M. Nimjee;Rebekah R. White;Richard C. Becker;Bruce A. Sullenger

477
Citations
Antidote-mediated control of an anticoagulant aptamer in vivo.

Christopher P Rusconi;Joseph D Roberts;George A Pitoc;Shahid M Nimjee

440
Citations
Developing aptamers into therapeutics

Rebekah R. White;Bruce A. Sullenger;Christopher P. Rusconi

404
Citations
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice

James O. McNamara;Despina Kolonias;Fernando Pastor;Robert S. Mittler

361
Citations
Generation of Species Cross-reactive Aptamers Using “Toggle” SELEX

Rebekah White;Christopher Rusconi;Elizabeth Scardino;Alisa Wolberg

361
Citations
Ribozyme-mediated repair of defective mRNA by targeted trans -splicing

Bruce A. Sullenger;Thomas R. Cech

347
Citations
From the RNA world to the clinic.

Bruce A. Sullenger;Smita Nair

338
Citations
In vivo selection of tumor-targeting RNA motifs

Jing Mi;Yingmiao Liu;Zahid N Rabbani;Zhongguang Yang

323
Citations
Gene therapy progress and prospects: RNA aptamers

N S Que-Gewirth;B A Sullenger

315
Citations
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer.

Nancy J. Ganson;Thomas J. Povsic;Bruce A. Sullenger;John H. Alexander

308
Citations
Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.

Petros A. Hantzopoulos;Bruce A. Sullenger;Grace Ungers;Eli Gilboa

277
Citations
Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA

Bruce A. Sullenger;Thomas R. Cech

277
Citations
Ribozyme-Mediated Repair of Sickle β-Globin mRNAs in Erythrocyte Precursors

Ning Lan;Richard P. Howrey;Seong-Wook Lee;Clayton A. Smith

274
Citations

Frequent Co-Authors

Smita Nair Duke University

Richard C. Becker University of Cincinnati

Eli Gilboa University of Miami

Kam W. Leong Columbia University

David S. Pisetsky Duke University

Joseph R. Nevins Duke University

Sriram Krishnaswamy Children's Hospital of Philadelphia

James O McNamara Duke University

Mark W. Dewhirst Duke University

Daniel J. George Duke University

External Links

Wikipedia of Bruce A. Sullenger Personal website of Bruce A. Sullenger

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA opens doors to a diverse range of academic and career opportunities in both clinical and research settings. Many students pursue further studies or specialized roles at the intersection of biology, psychology, and health sciences.

If you're interested in rapidly advancing your education, consider enrolling in an accelerated master's in psychology program. These programs offer a fast track to deepen your understanding of human behavior—knowledge that is increasingly valuable in biotechnology and health research companies.

For those drawn to counseling and support roles, an online masters in mental health counseling can prepare you for careers addressing the mental wellbeing of individuals in various settings. Furthermore, professionals interested in both science and criminal justice may explore careers in forensic psychology, where the biological sciences often intersect with legal investigations.

If your interests lean towards supporting younger populations, an online masters in child psychology provides specialized training to address the unique needs of children and adolescents—skills that complement backgrounds in molecular biology.

These pathways offer flexibility through online study options and can significantly broaden your expertise and career prospects after completing a molecular biology degree in the USA.